Descriptive epidemiology of 399 histologically confirmed newly diagnosed meningeal solitary fibrous tumours and haemangiopericytomas in France: 2006–2015
Acta Neurochirurgica · 2024
DOI: 10.1007/s00701-024-06191-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Neurochirurgica, 2024. Verfasst von Charles Champeaux Depond und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Hôpital Privé Clairval - Ramsay Santé, 317 Bd de Redon, 13009, Marseille, France. Charles.ChampeauxDepond@gmail.com. Hauptthemen laut MEDLINE: Hemangiopericytoma, Meningeal Neoplasms, Solitary Fibrous Tumors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National French Institute of Cancer, Committee 34, l’Association pour la Recherche sur les Tumeurs Cérébrales.
Abstract (Originalsprache)
PURPOSE: Meningeal solitary fibrous tumour (SFT) and haemangiopericytoma (HPC) are uncommon tumours that have been merged into a single entity in the last 2021 WHO Classification of Tumors of the Central Nervous System. To describe the epidemiology of SFT/HPC operated in France and, to assess their incidence. METHODS: We processed the French Brain Tumour Database (FBTDB) to conduct a nationwide population-based study of all histopathologically confirmed SFT/HPC between 2006 and 2015. RESULTS: Our study included 399 SFT/HPC patients, operated in France between 2006 and 2015, in one of the 46 participating neurosurgical centres. The incidence reached 0.062, 95%CI[0.056-0.068] for 100,000 person-years. SFT accounted for 35.8% and, HPC for 64.2%. The ratio of SFT/HPC over meningioma operated during the same period was 0.013. SFT/HPC are about equally distributed in women and men (55.9% vs. 44.1%). For the whole population, mean age at surgery was 53.9 (SD ± 15.8) years. The incidence of SFT/HPC surgery increases with the age and, is maximal for the 50-55 years category. Benign SFT/HPC accounted for 65.16%, SFT/HPC of uncertain behaviour for 11.53% and malignant ones for 23.31%. The number of resection progresses as the histopathological behaviour became more aggressive. 6.7% of the patients with a benign SFT/HPC had a second surgery vs.16.6% in case of uncertain behaviour and, 28.4% for malignant SFT/HPC patients. CONCLUSION: Meningeal SFT and HPC are rare CNS mesenchymal tumours which both share common epidemiological characteristics, asserting their merging under a common entity. SFT/HPC incidence is less that one case for 1 billion per year and, for around 100 meningiomas-like tumours removed, one SFT/HPC may be diagnosed. SFT/HPC are equally distributed in women and men and, are mainly diagnosed around 50-55 years. The more aggressive the tumour, the higher the probability of recurrence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Hôpital Privé Clairval - Ramsay Santé, 317 Bd de Redon, 13009, Marseille, France. Charles.ChampeauxDepond@gmail.com.
- Department of Neurosurgery, Gui de Chauliac Hospital, Montpellier University Medical Center, 34295, Montpellier Cedex 5, France.
- Institut de Génomique Fonctionnelle (IGF), University of Montpellier, CNRS, INSERM, 34094, Montpellier, France.
- Medical Oncology Department, Institut du Cancer de Montpellier, University of Montpellier, 34298, Montpellier, France.
- Department of Pathology, Gui-de-Chauliac Hospital, Montpellier University Medical Center, 34295, Montpellier Cedex 5, France.
- Department of Epidemiology, French Brain Tumour Database, GNOLR, Registre Des Tumeurs de L'Hérault, ICM, 34298, Montpellier Cedex 5, France.
ORCID-Profile: Charles Champeaux Depond, Sonia Zouaoui, Amélie Darlix, Valérie Rigau, Mohamed Khettab, Brigitte Trétarre, Dominique Figarella-Branger, Luc Taillandier, Julien Boetto, Johan Pallud, Mathieu Peyre, Marine Lottin, Luc Bauchet
Förderung
- National French Institute of Cancer
- Committee 34
- l’Association pour la Recherche sur les Tumeurs Cérébrales
- ANOCEF
- SFNC
- département de l’Hérault
- Groupe de Neuro-oncologie du Languedoc Roussillon
Zitieren
APA
Champeaux Depond, C., Zouaoui, S., Darlix, A., Rigau, V., Mathieu-Daudé, H., Bauchet, F., Khettab, M., Trétarre, B., Figarella-Branger, D., Taillandier, L., Boetto, J., Pallud, J., Peyre, M., Lottin, M., Bauchet, L., & French Brain Tumour DataBase (FBTDB) Participants and Investigators with the participation of the Société française de neurochirurgie (SFNC), Club de neuro-onc… (2024). Descriptive epidemiology of 399 histologically confirmed newly diagnosed meningeal solitary fibrous tumours and haemangiopericytomas in France: 2006–2015. Acta Neurochirurgica. https://doi.org/10.1007/s00701-024-06191-y
Vancouver
Champeaux Depond C, Zouaoui S, Darlix A, Rigau V, Mathieu-Daudé H, Bauchet F, et al. Descriptive epidemiology of 399 histologically confirmed newly diagnosed meningeal solitary fibrous tumours and haemangiopericytomas in France: 2006–2015. Acta Neurochirurgica. 2024. doi:10.1007/s00701-024-06191-y
BibTeX
@article{ChampeauxDepond2024,
author = {Champeaux Depond, Charles and Zouaoui, Sonia and Darlix, Amélie and Rigau, Valérie and Mathieu-Daudé, Hélène and Bauchet, Fabienne and Khettab, Mohamed and Trétarre, Brigitte and Figarella-Branger, Dominique and Taillandier, Luc and Boetto, Julien and Pallud, Johan and Peyre, Mathieu and Lottin, Marine and Bauchet, Luc and French Brain Tumour DataBase (FBTDB) Participants and Investigators with the participation of the Société française de neurochirurgie (SFNC), Club de neuro-onc…, French Brain Tumour DataBase (FBTDB) Participants and Investigators with the participation of the Société française de neurochirurgie (SFNC), Club de neuro-onc…},
title = {Descriptive epidemiology of 399 histologically confirmed newly diagnosed meningeal solitary fibrous tumours and haemangiopericytomas in France: 2006–2015},
journal = {Acta Neurochirurgica},
year = {2024},
doi = {10.1007/s00701-024-06191-y}
}
EUVIMED